Buy, Hold, or Sell: Lam Research Rocketed 21% Off Its June Lows as a New Fed Begins. Is LRCX Worthwhile at $366?
📈 Lam Research shares rocketed 21% in one week to $366.81 as softer rates and a fresh Fed posture reset risk appetite across semicap.
💰 Q3 FY26 revenue hit $5.84 billion, up 23.76% year over year, with non-GAAP EPS of $1.47 against a $1.36 consensus.
🚀 June-quarter guidance calls for $6.60 billion in revenue and $1.65 in EPS, representing an unanticipated sequential acceleration.
🏭 Management upgraded the global wafer-fab equipment outlook to $140 billion as customers transition to high-density 3D NAND stacks.
📊 Operating margin expanded to 35.0% from 33.9% sequentially, with return on equity sitting at a robust 66.8%.
🔍 Barclays lifted its price target to $335 from $275, though the current price sits above this consensus level.
⚠️ Valuation concerns persist with a forward P/E of roughly 47 and trailing P/E near 69, both above five-year group averages.
🇨🇳 China generated $1.99 billion in revenue (34% of total), exposing the franchise to risks from export-control tightening.
📉 Insider activity turned net selling across seven recent transactions while free cash flow fell 20.65% year over year.
📉 The stock is up 114.53% year to date and 303.12% over the past year, significantly outperforming the S&P 500.
🎯 Analysts recommend a Hold stance as the bull thesis remains intact but the entry price has stretched relative to historical norms.
📉 A pullback into the $330 zone is identified as the technical reset that would restore reasonable risk/reward ratios.
🔮 The specific trigger for a better entry point is consolidation into the $330 zone where the forward multiple compresses toward 40.
⚡ A break above $375 on confirmed June-quarter execution would force a different conversation regarding the stock's valuation.
🛑 Chasing the stock into its 52-week high with insiders distributing is characterized as a thin edge for investors.
- Lam Research delivered record revenue and EPS in the March quarter, driven by AI demand reshaping the semiconductor industry.
- The company holds an entrenched position in deposition and etch tools required for high-density 3D NAND stacks and advanced packaging.
- Operating margins expanded sequentially to 35.0%, demonstrating strong operational efficiency amidst growth.
- Barclays lifted its price target to $335, indicating institutional confidence in the upgraded $140 billion global wafer-fab equipment outlook.
- The stock has outperformed the broader market significantly, rising 303.12% over the past year compared to the S&P 500's 22.86% gain.
- Management guidance for the June quarter shows sequential acceleration in both revenue and EPS, exceeding prior expectations.
- The stock trades at a forward P/E of roughly 47 and trailing P/E near 69, which are above five-year group averages and suggest high valuation.
- China generated $1.99 billion in revenue, representing 34% of last quarter's total, which exposes the franchise to export-control tightening risks.
- Insider activity turned net selling across seven recent transactions, potentially signaling a lack of confidence from top-level executives at current prices.
- Free cash flow fell 20.65% year over year despite the revenue beat, indicating potential liquidity or investment pressure.
- The stock is trading $373.82 from its 52-week peak, suggesting asymmetry has flipped and entry points are less attractive at current highs.
- A 21% one-week move driven by macro relief rather than fresh fundamentals is a type of squeeze that often retraces before extending.